Dear John,

A new Fraser Institute study out today finds that Canadian patients are waiting, on average, more than 450 days longer than Americans and Europeans to access new, potentially life-saving drugs.

It's because pharmaceutical companies are reluctant to launch new drugs in Canada.

Why is that?

There are a number of reasons – the smaller market size, weaker intellectual property protections, and the federal government’s strict pricing policies.

Learn more on what can be done to address this by checking out the full study here [[link removed] [link removed]], and be sure to share it with your friends and colleagues!

Stay safe,

Niels Veldhuis

President

STAY UP TO DATE

SUPPORT THE FRASER INSTITUTE

The Fraser Institute has been ranked the #1 think tank in Canada, and the 14th best think tank out of more than 8,200 around the world! We keep Canadians – and decision-makers! – informed.

But we are only as strong as our supporters. We do not accept government grants or payments for research - we depend on individuals like you to continue our good work! We are a charity - your donation entitles you to a generous tax credit at tax time!

Contact Us [[link removed]] Privacy Policy [[link removed]] Unsubscribe [link removed] The Fraser Institute's mission is to improve the quality of life for Canadians, their families and future generations by studying, measuring and broadly communicating the effects of government policies, entrepreneurship and choice on their well-being. Email is one of the best tools we have to accomplish these goals. If you no longer wish to receive e-mail updates from us, click here to unsubscribe [link removed].

Fraser Institute 4th Floor, 1770 Burrard Street Vancouver, BC V6J 3G7